Renaissance Technologies
CDLX icon

Renaissance Technologies’s Cardlytics CDLX Stock Holding History

Renaissance Technologies’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.6K Buy
18,405
+7,155
+64% +$53.5K ﹤0.01% 3000
2026
Q1 		$118K Buy
11,250
+5,850
+108% +$57.1K ﹤0.01% 3005
2025
Q4 		$62.1K Buy
+5,400
New +$83.4K ﹤0.01% 3070
2025
Q3 		– Sell
-12,058
Closed -$198K – 3541
2025
Q2 		$198K Buy
+12,058
New +$208K ﹤0.01% 3172
2025
Q1 		– Sell
-40,341
Closed -$1.5M – 3500
2024
Q4 		$1.5M Sell
40,341
-753
-2% -$28.8K ﹤0.01% 2237
2024
Q3 		$1.31M Buy
41,094
+5,990
+17% +$332K ﹤0.01% 2288
2024
Q2 		$2.88M Buy
35,104
+30,780
+712% +$3.33M ﹤0.01% 1642
2024
Q1 		$626K Sell
4,324
-9,760
-69% -$824K ﹤0.01% 2772
2023
Q4 		$1.3M Buy
14,084
+7,290
+107% +$741K ﹤0.01% 2231
2023
Q3 		$1.12M Buy
+6,794
New +$883K ﹤0.01% 2221
2022
Q4 		– Sell
-22,774
Closed -$2.14M – 4134
2022
Q3 		$2.14M Buy
22,774
+13,620
+149% +$1.94M ﹤0.01% 1969
2022
Q2 		$2.04M Buy
9,154
+880
+11% +$295K ﹤0.01% 2175
2022
Q1 		$4.55M Sell
8,274
-7,213
-47% -$4.36M 0.01% 1667
2021
Q4 		$10.2M Buy
15,487
+13,803
+820% +$10.6M 0.01% 1061
2021
Q3 		$1.41M Sell
1,684
-6,050
-78% -$6.14M ﹤0.01% 2351
2021
Q2 		$9.82M Buy
+7,734
New +$8.73M 0.01% 1186
2020
Q2 		– Sell
-23,734
Closed -$8.3M – 3464
2020
Q1 		$8.3M Sell
23,734
-13,980
-37% -$9.9M 0.01% 1275
2019
Q4 		$23.7M Buy
37,714
+27,420
+266% +$13.4M 0.02% 917
2019
Q3 		$3.45M Buy
+10,294
New +$3.3M ﹤0.01% 1994

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Renaissance Technologies's CDLX Position: Q2 2026 in Review

Renaissance Technologies increased its Cardlytics (CDLX) stake by 64% in Q2 2026, buying an estimated $53.5K and bringing the position to 18,405 shares worth $82.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3000.

Renaissance Technologies first reported a position in CDLX in Q3 2019 and has held it in 19 quarters since. The position peaked at $23.7M in Q4 2019. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Renaissance Technologies held 18,405 shares of Cardlytics worth $82.6K as of Q2 2026.
  • Renaissance Technologies bought 7,155 Cardlytics shares in Q2 2026, an estimated $53.5K.
  • Cardlytics made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3000 holding.
  • Renaissance Technologies first reported a position in Cardlytics in Q3 2019 and has held it in 19 quarters since.
  • Renaissance Technologies's Cardlytics position peaked at $23.7M in Q4 2019.
  • 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.